Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04557059
Title A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Positive Hormone-Sensitive Prostate Cancer Participants (PRIMORDIUM)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Janssen Pharmaceutica N.V., Belgium
Indications

prostate adenocarcinoma

Therapies

Apalutamide + Triptorelin

Triptorelin

Apalutamide + Goserelin

Apalutamide + Leuprolide

Leuprolide

Goserelin

Age Groups: adult | senior
Covered Countries ITA | ESP | BEL | AUT


No variant requirements are available.